.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research highlights a significant rise in diabetes in pregnancy risks, specifically regarding gestational diabetes mellitus (GDM) and pregestational type 2 diabetes. According to data from the Healthcare Cost and Utilization Project, GDM prevalence increased from 7.1 to 9.5 per 100 deliveries between 2016 and 2022. Consequently, healthcare providers must address these trends to prevent adverse outcomes. Furthermore, the rising incidence of diabetes mirrors a broader increase in severe maternal morbidity (SMM) across the United States.
While GDM is the most common form of the condition, pregestational diabetes presents even higher clinical challenges. Specifically, type 1 diabetes was associated with the highest risk of nontransfusion SMM. However, type 2 diabetes and GDM also showed clear associations with increased morbidity. Therefore, comprehensive monitoring is essential for all pregnant women with glycemic disorders. Additionally, multidisciplinary care teams should focus on cardiometabolic risk management during both the pregnancy and the delivery stages.
Moreover, the study revealed that overall SMM increased from 160.0 to 220.3 per 10,000 deliveries during the study period. This upward trend underscores the need for localized clinical interventions. Since the prevalence of type 2 diabetes continues to rise, clinicians must be proactive. In conclusion, managing these conditions requires a robust framework of specialized care to safeguard maternal health.
Pregestational type 1 diabetes is associated with the highest relative risk for nontransfusion severe maternal morbidity, followed by type 2 diabetes and gestational diabetes.
The prevalence of gestational diabetes in delivery hospitalizations rose from 7.1 per 100 deliveries in 2016 to 9.5 per 100 deliveries in 2022.
Multidisciplinary care is crucial because all forms of diabetes in pregnancy are linked to increased morbidity, requiring coordinated management of cardiometabolic and obstetric risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A large-scale retrospective study reveals a sharp rise in gestational and type 2 diabetes alongside severe maternal morbidity between 2016 and 2022. While gestational diabetes is most prevalent, type 1 diabetes poses the highest risk for maternal complications, necessitating multidisciplinary care.
2 months ago
A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
